Cabaletta Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.

About CABA

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. 

CEO
Steven Nichtberger
CEOSteven Nichtberger
Employees
156
Employees156
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2017
Founded2017
Employees
156
Employees156

CABA Key Statistics

Market cap
268.10M
Market cap268.10M
Price-Earnings ratio
-1.21
Price-Earnings ratio-1.21
Dividend yield
Dividend yield
Average volume
1.91M
Average volume1.91M
High today
$2.88
High today$2.88
Low today
$2.73
Low today$2.73
Open price
$2.75
Open price$2.75
Volume
1.49M
Volume1.49M
52 Week high
$3.78
52 Week high$3.78
52 Week low
$0.9857
52 Week low$0.9857

Stock Snapshot

With a market cap of 268.1M, Cabaletta Bio(CABA) trades at $2.78. The stock has a price-to-earnings ratio of -1.21.

During the trading session on 2026-03-25, Cabaletta Bio(CABA) shares reached a daily high of $2.88 and a low of $2.73. At a current price of $2.78, the stock is +1.8% higher than the low and still -3.4% under the high.

Trading activity shows a volume of 1.49M, compared to an average daily volume of 1.91M.

The stock's 52-week range extends from a low of $0.99 to a high of $3.78.

The stock's 52-week range extends from a low of $0.99 to a high of $3.78.

CABA News

TipRanks 3d
Cabaletta Bio Updates Rese-cel Programs and Financial Outlook

Cabaletta Bio ( (CABA) ) has provided an announcement. On March 23, 2026, Cabaletta Bio reported fourth-quarter and full-year 2025 results and outlined progres...

TipRanks 3d
Cabaletta Bio reports Q4 EPS (40c), consensus (47c)

As of December 31, 2025, Cabaletta had cash, cash equivalents and short-term investments of $133.6M, compared to $164M as of December 31, 2024. “As we advance o...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own CABA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.